Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors at 3 institutions in 1 country.
Simon GraspeuntnerDepartment of Infectious Diseases and Microbiology, University of Luebeck, 23538 Luebeck, Germany.ORCID 0000-0002-2546-2223
Katharina KoethkeDepartment of Infectious Diseases and Microbiology, University of Luebeck, 23538 Luebeck, Germany.
Celeste ScholzDepartment of Infectious Diseases and Microbiology, University of Luebeck, 23538 Luebeck, Germany.
Lea SemmlerDepartment of Infectious Diseases and Microbiology, University of Luebeck, 23538 Luebeck, Germany.
Mariia LupatsiiDepartment of Infectious Diseases and Microbiology, University of Luebeck, 23538 Luebeck, Germany.
Laura KirchhoffDepartment of Infectious Diseases and Microbiology, University of Luebeck, 23538 Luebeck, Germany.
Jennifer HerrmannHelmholtz Centre for Infection Research (HZI), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), and Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany.ORCID 0000-0003-3398-9938
Katharina RoxGerman Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany.ORCID 0000-0002-8020-1384
Kathrin WittsteinGerman Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany.
Nadja KädingDepartment of Infectious Diseases and Microbiology, University of Luebeck, 23538 Luebeck, Germany.
Lars C HankerDepartment of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, 23538 Luebeck, Germany.
Marc StadlerGerman Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany.ORCID 0000-0002-7284-8671
Mark BrönstrupGerman Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany.ORCID 0000-0002-8971-7045
Rolf MüllerHelmholtz Centre for Infection Research (HZI), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), and Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany.ORCID 0000-0002-1042-5665
Kensuke ShimaDepartment of Infectious Diseases and Microbiology, University of Luebeck, 23538 Luebeck, Germany.ORCID 0000-0002-5357-4230
Jan RuppDepartment of Infectious Diseases and Microbiology, University of Luebeck, 23538 Luebeck, Germany.
German Center for Infection Research · DEUniversity of Lübeck · DEUniversity Hospital Schleswig-Holstein · DE
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Sorangicin A Is Active against · full record | OpenQuestion